https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2022.895476/full
Introduction: Monoclonal antibodies (mAbs) showed efficacy in migraine prevention. The aim of this study was to check if baseline clinical parameters and cer...
cerebral blood flowfrontierspredictorsresponsiveness
https://www.ajmc.com/view/data-highlight-longterm-efficacy-of-erenumab-for-episodic-migraine
In patients with episodic migraine, erenumab provided sustained efficacy for the condition over the course of 1 year, according to new results from a study to...
long termepisodic migrainedatahighlightefficacy
https://www.clinicaltrialsarena.com/projects/aimovig-erenumab-treatment-episodic-migraine/
Aimovig (erenumab) is the first CGRP inhibitor approved for the preventive treatment of migraine in adults.
episodic migraineaimovigerenumabtreatment
https://www.goodrx.com/aimovig/what-is
Learn about Aimovig (erenumab) usage and dosing. Read the latest news and reviews about the drug as well as potential side effects and popular alternatives.
side effectsaimovigerenumabusesdosage
https://www.tga.gov.au/resources/artg/289959
Australian Register of Therapeutic Goods (ARTG) information for AIMOVIG erenumab (rch) 70 mg/mL solution for injection in pre-filled pen.
aimovigerenumabrchmgml
https://www.iasp-pain.org/publications/pain-research-forum/papers-of-the-week/paper/early-use-of-erenumab-vs-nonspecific-oral-migraine-preventives-the-appraise-randomized-clinical-trial/
Patients with migraine often cycle through multiple nonspecific preventive medications due to poor tolerability and/or inadequate efficacy leading to low...
earlyuseerenumabvsnonspecific